Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment
Tarih
2015Yazar
Duman, Berna
Musellim, Benan
Mazican, Nejdiye
Hamuryudan, Vedat
Ozguler, Yesim
Ongen, Gul
Atahan, Ersan
Yilmaz, Deniz Demir
Borekci, Sermin
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).
Koleksiyonlar
- Makale [92796]